These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25946929)

  • 21. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
    Kuna P; Jenkins M; O'Brien CD; Fahy WA
    Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.
    Watz H; Barnacle H; Hartley BF; Chan R
    Lancet Respir Med; 2014 Jan; 2(1):63-72. PubMed ID: 24461903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of High-Dose Vitamin D Replacement on the Serum Levels of Systemic Inflammatory Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Dastan F; Salamzadeh J; Pourrashid MH; Edalatifard M; Eslaminejad A
    COPD; 2019 Aug; 16(3-4):278-283. PubMed ID: 31550915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD.
    Abrahams R; Moroni-Zentgraf P; Ramsdell J; Schmidt H; Joseph E; Karpel J
    Respir Med; 2013 Jun; 107(6):854-62. PubMed ID: 23490224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of periodontal treatment on lung function and exacerbation frequency in patients with chronic obstructive pulmonary disease and chronic periodontitis: a 2-year pilot randomized controlled trial.
    Zhou X; Han J; Liu Z; Song Y; Wang Z; Sun Z
    J Clin Periodontol; 2014 Jun; 41(6):564-72. PubMed ID: 24593836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trials.
    Wedzicha JA; Buhl R; Lawrence D; Young D
    Respir Med; 2015 Jan; 109(1):105-11. PubMed ID: 25433954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of vitamin D therapy for patients with COPD: a meta-analysis of randomized controlled trials.
    Li X; He J; Yu M; Sun J
    Ann Palliat Med; 2020 Mar; 9(2):286-297. PubMed ID: 32156131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD.
    Kerwin EM; Scott-Wilson C; Sanford L; Rennard S; Agusti A; Barnes N; Crim C
    Respir Med; 2013 Apr; 107(4):560-9. PubMed ID: 23352226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D.
    Kerstjens HA; Deslée G; Dahl R; Donohue JF; Young D; Lawrence D; Kornmann O
    Pulm Pharmacol Ther; 2015 Jun; 32():101-8. PubMed ID: 25743376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
    Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM
    Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
    Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
    Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum magnesium and not vitamin D is associated with better QoL in COPD: A cross-sectional study.
    Hashim Ali Hussein S; Nielsen LP; Konow Bøgebjerg Dolberg M; Dahl R
    Respir Med; 2015 Jun; 109(6):727-33. PubMed ID: 25892292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
    Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
    Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study.
    Fukuchi Y; Tatsumi K; Inoue H; Sakata Y; Shibata K; Miyagishi H; Marukawa Y; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():831-8. PubMed ID: 27143873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.
    Cazzola M; Andò F; Santus P; Ruggeri P; Di Marco F; Sanduzzi A; D'Amato M
    Pulm Pharmacol Ther; 2007; 20(5):556-61. PubMed ID: 16914336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results.
    Fukuchi Y; Samoro R; Fassakhov R; Taniguchi H; Ekelund J; Carlsson LG; Ichinose M
    Respirology; 2013 Jul; 18(5):866-73. PubMed ID: 23551359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Monthly, High-Dose, Long-Term Vitamin D on Lung Function: A Randomized Controlled Trial.
    Sluyter JD; Camargo CA; Waayer D; Lawes CMM; Toop L; Khaw KT; Scragg R
    Nutrients; 2017 Dec; 9(12):. PubMed ID: 29236049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial.
    Sanjari M; Soltani A; Habibi Khorasani A; Zareinejad M
    J Diabetes Metab Disord; 2015; 15(1):33. PubMed ID: 27570748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.